| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document Help

Title:Upravljanje tveganj in zagotavljanje neprekinjenega poslovanja pri dobavi inovativnih zdravil : magistrsko delo
Authors:ID Korošec, Matjaž (Author)
ID Jereb, Borut (Mentor) More about this mentor... New window
ID Orel Šanko, Nena (Comentor)
Files:.pdf MAG_Korosec_Matjaz_2025.pdf (1,39 MB)
MD5: 4CA6C633D7E1A9276D038CD206F626F1
 
Language:Slovenian
Work type:Master's thesis/paper
Typology:2.09 - Master's Thesis
Organization:FL - Faculty of Logistic
Abstract:Magistrsko delo obravnava problematiko upravljanja tveganj in zagotavljanja neprekinjenega poslovanja pri dobavi inovativnih zdravil. Neprekinjena dobava teh zdravil je ključnega pomena, saj neposredno vpliva na življenje in zdravje pacientov. Farmacevtska podjetja se soočajo z različnimi izzivi, kot so globalne pandemije, politični konflikti, makroekonomska nestabilnost in ekstremni vremenski pojavi, kar zahteva robustne sisteme za obvladovanje tveganj. V nalogi je predstavljen proces strateškega upravljanja tveganj v skladu z ISO 31000 in vzpostavitev sistema neprekinjenega poslovanja v skladu z ISO 22301 v enem izmed vodilnih farmacevtskih podjetij. Preučene so ključne razlike in izboljšave, ki so jih prinesli ti sistemi, zlasti v kontekstu pozitivnega vpliva na paciente. Naloga analizira tveganja v oskrbovalni verigi, od dobave osnovnih materialov do končnega uporabnika, ter predstavlja koncept inovativnih zdravil, ki so zaradi svoje narave izpostavljena dodatnim tveganjem. Glavni cilj naloge je pokazati pomen učinkovitega upravljanja tveganj za zagotavljanje neprekinjene dostave zdravil, kar posledično zmanjšuje stroške in etične izzive ter izboljšuje zdravstvene izide pacientov.
Keywords:tveganje, inovativno zdravilo, neprekinjeno poslovanje, nabavna veriga
Place of publishing:Maribor
Place of performance:Celje
Publisher:[M. Korošec]
Year of publishing:2025
Number of pages:1 spletni vir (1 datoteka PDF (XII, 59 str.))
PID:20.500.12556/DKUM-92301 New window
UDC:658.788:661.12(043.2)
COBISS.SI-ID:235907587 New window
Publication date in DKUM:14.05.2025
Views:168
Downloads:31
Metadata:XML DC-XML DC-RDF
Categories:FL
:
Copy citation
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share



Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.
Licensing start date:31.03.2025

Secondary language

Language:English
Title:Ensuring an uninterrupted supply of innovative medicines through the implementation of business continuity and holistic risk management systems
Abstract:The master's thesis addresses the issue of risk management and business continuity in the supply chain of innovative pharmaceuticals. The uninterrupted supply of these medicines is crucial as it directly impacts the lives and health of patients. Pharmaceutical companies face various challenges, such as global pandemics, political conflicts, macroeconomic instability, and extreme weather events, necessitating robust risk management systems. The thesis presents the process of strategic risk management in accordance with ISO 31000 and the implementation of a business continuity system in accordance with ISO 22301 in one of the leading pharmaceutical companies. It examines the key differences and improvements brought by these systems, particularly in terms of their positive impact on patients. The thesis analyzes risks within the supply chain, from the procurement of raw materials to the end user, and introduces the concept of innovative medicines, which are exposed to additional risks due to their nature. The main goal of the thesis is to demonstrate the importance of effective risk management in ensuring the uninterrupted delivery of medicines, which in turn reduces costs and ethical challenges while improving patient health outcomes.
Keywords:risk management, inovative medicine, business continuity, supply chain


Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica